Effect of Imidapril, an Angiotensin-converting Enzyme Inhibitor, on Fructose-induced Insulin Resistance in Rats

Endocrine Journal

Volumn 51, Issue 1, 2004, Pages 69-74

  Oda, Tsuneyuki ^a   Hirata, Masanobu ^a   Oshida, Yoshiharu ^a   Han, Yan Qing ^a   Koshinaka, Keiichi ^a   Sato, Yuzo ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

ACE inhibitor; Insulin sensitivity; Nitric oxide

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; IMIDAPRIL; INSULIN; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RADIOIMMUNOASSAY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADMINISTRATION, ORAL; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FRUCTOSE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; IMIDAZOLES; IMIDAZOLIDINES; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; MALE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RATS; RATS, WISTAR;

EID: 1642504268     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.51.69     Document Type: Article

References (21)

1. Olefsky JM, Kolterman OG (1981) Mechanisms of insulin resistance in obesity and non-insulin-dependent (type II) diabetes. Am J Med 70: 151-168.
2. Goodyear L, Smith RJ (1994) Exercise and diabetes. In: Kahn CR, Weir GC (eds) Joslin's Diabetes Mellitus, Philadelphia: Lea Febiger. 451-459.
3. Clark CM Jr, Lee DA (1995) Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 332: 1210-1217.
4. Farhy RD, Carretero OA, Ho KL, Scicli AG (1993) Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 72: 1202-1210.
5. Higashi Y, Oshima T, Sasaki S, Nakano K, Kambe M, Matsuura H, Kajiyama G (1998) Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension. Hypertension 32: 16-24.
6. Henriksen EJ, Jacob S, Tritscher HJ, Augustin HJ, Dietze GJ (1996) Glucose-transport activity in insulin-resistant rat muscle. Effect of angiotensin-converting enzyme inhibitors and bradykinin antagonism. Diabetes 45: S 125-S 128.
7. Nakagawa H, Daihara M, Tamakawa H, Nozue T (1999) Effect of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities. J Cardiovasc Pharmacol 34: 28-33.
8. Uehara M, Kishikawa H, Isami S, Kisanuki K, Ohkubo Y, Miyamura Y, Miyata T, Yano T, Shichiri M (1994) Effect of insulin sensitivity of angiotensin-converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37: 300-307.
9. Damas J, Bourdon V, Lefebvre PJ (1999) Insulin sensitivity, clearance and release in kininogen-deficient rats. Exp Physiol 84: 549-557.
10. Tomiyama H, Kushiro T, Abeta H, Ishii T, Takahashi A, Furukawa L, Asagami T, Hino T, Saito F, Otsuka Y, Kurumatani H, Kobayashi F, Kanmatsuse K, Kajiwara N (1994) Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin-converting enzyme inhibitor. Hypertension 23: 450-455.
11. Arbin V, Claperon N, Fournie-Zaluski M-C, Roques BP, Peyroux J (2001) Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat. Br J Pharmacol 133: 495-502.
12. Henriksen EJ, Jacob S, Kinnick TR, Youngblood EB, Schmit MB, Dietze GJ (1999) ACE inhibition and glucose transport in insulin-resistance muscle. Role of bradykinin and nitric oxide. Am J Physiol 277: R332-R336.
13. Oshida Y, Tachi Y, Morishita Y, Kitakoshi K, Fuku N, Han Y-Q, Ohsawa I, Sato Y (2000) Nitric oxide decreases insulin resistance induced by high-fructose feeding. Horm Metab Res 32: 339-342.
14. Carvalho CRO, Thirone ACP, Gontijo JAR, Velloso LA, Saad MJA (1997) Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes 46: 1950-1957.
15. Nawano M, Anai M, Funaki M, Kobayashi H, Kanda A, Fukushima Y, Inukai K, Ogihara T, Sakoda H, Onishi Y, Kikuchi M, Yazaki Y, Oka Y, Asano T (1999) Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Metabolism 48: 1248-1255.
16. Miyata T, Taguchi T, Uehara M, Isami S, Kishikawa H, Kaneko K, Araki E, Shichiri M (1998) Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dogs skeletal muscle and rat L6 myoblasts. Eur J Endocrinol 138: 344-352.
17. Henriksen EJ, Jacob S (1995) Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 44: 267-272.
18. Gardiner SM, Kemp PA, March JE, Bennett T (1995) Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharm 116: 2005-2016.
19. Han Y-Q, Oshida Y, Li L, Koshinaka K, Fuku N, Yamanouchi K, Sato Y (2001) Effect of voluntary wheel-running on insulin sensitivity and responsiveness in high-fat-fed rats. Endocri J 48: 551-555.
20. Roy D, Perreault M, Marette A (1998) Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 274: E692-E699.
21. Koshinaka K, Oshida Y, Han Y-Q, Ohsawa I, Sato Y (2004) The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats. Metabolism 53: 22-27.